Introduction: Endoplasmic reticulum stress (ERS) is associated with the occurrence and development of colorectal cancer (CRC). Methods: One thousand nine CRC samples and 3 ERS gene sets from GEO database were used to screen and validate genes related to stage and prognosis of CRC. Twenty thousand five hundred thirty samples from the TCGA database validated the ERS genes related to prognosis. PPI network construction and coexpression analysis were used to investigate the correlation of genes. ConsensusClusterPlus analysis was used to classify CRC subtypes. Cox regression and the LASSO algorithm were used to screen ERS genes related to prognosis. HE staining, immunohistochemical staining, and RT-qPCR of 50 owner-central samples were used to verify the genes. The ERscore model was constructed based on the ERS genes related to prognosis. The nomogram model was used to verify that different subtypes of CRC patients have different prognosis. Results: Fifty ERS differentially expressed genes related to CRC stage and 8 ERS model genes related to prognosis were screened. Three subtypes of CRC were classified based on the former 50 genes. The clinical characteristics were significantly different among the subtypes. The ERscore model was constructed based on the latter 8 genes, and its accuracy was verified by clinical samples. Finally, the nomogram was constructed based on ERscore, age, and CRC stage, and the accuracy of the nomogram prediction was verified. Conclusion: ERS-related genes can be used as classification criteria for CRC, and the related clinical characteristics of different CRC subtypes are different.

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002–13.
Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–502.
Luo XJ, Zhao Q, Liu J, Zheng JB, Qiu MZ, Ju HQ, et al. Novel genetic and epigenetic biomarkers of prognostic and predictive significance in stage II/III colorectal cancer. Mol Ther. 2021;29(2):587–96.
Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350–6.
Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21(2):71–88.
Gao H, He C, Hua R, Guo Y, Wang B, Liang C, et al. Endoplasmic reticulum stress of gut enterocyte and intestinal diseases. Front Mol Biosci. 2022;9:817392.
Yu W, Xu G, Chen H, Xiao L, Liu G, Hu P, et al. The substitution of SERCA2 redox cysteine 674 promotes pulmonary vascular remodeling by activating IRE1α/XBP1s pathway. Acta Pharm Sin B. 2022;12(5):2315–29.
Motawi TK, Al-Kady RH, Abdelraouf SM, Senousy MA. Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson’s disease in rats: targeting the GRP78/PERK/eIF2α/CHOP pathway and miR-211-5p. Chem Biol Interact. 2022;362:110002.
Zhang HH, Li C, Ren JW, Liu L, Du XH, Gao J, et al. OTUB1 facilitates bladder cancer progression by stabilizing ATF6 in response to endoplasmic reticulum stress. Cancer Sci. 2021;112(6):2199–209.
Jiang W, Chen L, Guo X, Cheng C, Luo Y, Wang J, et al. Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy. Theranostics. 2022;12(6):2987–3006.
Yang C, Wei Y, Li W, Wei J, Chen G, Xu M, et al. Prognostic risk signature and comprehensive analyses of endoplasmic reticulum stress-related genes in lung adenocarcinoma. J Immunol Res. 2022:2022:6567916.
Tan M, Wang H, Gao C, Jiang Z, Yin Y, Xing R, et al. Agonists specific for κ-opioid receptor induces apoptosis of HCC cells through enhanced endoplasmic reticulum stress. Front Oncol. 2022;12:844214.
Ala M. Sestrin2 in cancer: a foe or a friend?Biomark Res. 2022;10(1):29.
Liu C, Xu J, Guo C, Chen X, Qian C, Zhang X, et al. Gambogenic acid induces endoplasmic reticulum stress in colorectal cancer via the aurora a pathway. Front Cell Dev Biol. 2021;9:736350.
Zhao Q, Bi Y, Guo J, Liu Y, Zhong J, Liu Y, et al. Effect of pristimerin on apoptosis through activation of ROS/endoplasmic reticulum (ER) stress-mediated noxa in colorectal cancer. Phytomedicine. 2021;80:153399.
Qi H, Zhang X, Liu H, Han M, Tang X, Qu S, et al. Shikonin induced apoptosis mediated by endoplasmic reticulum stress in colorectal cancer cells. J Cancer. 2022;13(1):243–52.
Liang X, Xie J, Liu H, Zhao R, Zhang W, Wang H, et al. STIM1 deficiency in intestinal epithelium attenuates colonic inflammation and tumorigenesis by reducing ER stress of goblet cells. Cell Mol Gastroenterol Hepatol. 2022;14(1):193–217.
Xiong J, Xiong S, Feng X, Zhang H, Su Q. Identification of a 5-nutrient stress-sensitive gene signature to predict survival for colorectal cancer. Biomed Res Int. 2022:2022:2587120.
Chen X, Gao K, Xiang Z, Zhang Y, Peng X. Identification and validation of an endoplasmic reticulum stress-related lncRNA signature for colon adenocarcinoma patients. Int J Gen Med. 2022;15:4303–19.
Liu CY, Hsu CC, Huang TT, Lee CH, Chen JL, Yang SH, et al. ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer. Mol Oncol. 2018;12(10):1706–17.
Van Anken E, Bakunts A, Hu CA, Janssens S, Sitia R. Molecular evaluation of endoplasmic reticulum homeostasis meets humoral immunity. Trends Cell Biol. 2021;31(7):529–41.
Li L, Yang Z, Zheng Y, Chen Z, Yue X, Bian E, et al. Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma. BMC Neurol. 2022;22(1):192.
Li Q, Chen C, Kong J, Li L, Li J, Huang Y. Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade. Acta Pharm Sin B. 2022;12(5):2533–49.
Fan Y, Liang X, Yu D. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma. Aging. 2021;13(19):23036–71.
Salaroglio IC, Panada E, Moiso E, Buondonno I, Provero P, Rubinstein M, et al. PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy. Mol Cancer. 2017;16(1):91.
Avril T, Vauléon E, Chevet E. Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers. Oncogenesis. 2017;6(8):e373.
Liu B, Yin X, Jiang G, Li Y, Jiang Z, Qiang L, et al. Identification of endoplasmic reticulum stress-related subtypes, infiltration analysis of tumor microenvironment, and construction of a prognostic model in colorectal cancer. Cancers. 2022;14(14):3326.
Ryan D, Carberry S, Murphy ÁC, Lindner AU, Fay J, Hector S, et al. Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer. J Transl Med. 2016;14(1):196.
Wang X, Zhang M, Xiong XQ, Yang H, Wang P, Zhang K, et al. Design, synthesis and bioactivity of novel naphthalimide-benzotriazole conjugates against A549 cells via targeting BCL2 G-quadruplex and inducing autophagy. Life Sci. 2022;302:120651.
Liang J, Cao R, Wang X, Zhang Y, Wang P, Gao H, et al. Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2. Cell Res. 2017;27(3):329–51.
Zhang X, Wang L, Ireland SC, Ahat E, Li J, Bekier ME2nd, et al. GORASP2/GRASP55 collaborates with the PtdIns3K UVRAG complex to facilitate autophagosome-lysosome fusion. Autophagy. 2019;15(10):1787–800.
Husni RE, Shiba-Ishii A, Nakagawa T, Dai T, Kim Y, Hong J, et al. DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma. Oncotarget. 2019;10(17):1625–36.
Yu H, Liu F, Chen K, Xu Y, Wang Y, Fu L, et al. The eif2ak4/rs4594236 AG/GG genotype is a hazard factor of immunoglobulin therapy resistance in southern Chinese kawasaki disease patients. Front Genet. 2022;13:868159.
Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, et al. Phenotypic characterization of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension. Circulation. 2017;136(21):2022–33.
Alasiri G, Jiramongkol Y, Trakansuebkul S, Ke HL, Mahmud Z, Intuyod K, et al. Reciprocal regulation between GCN2 (eIF2AK4) and PERK (eIF2AK3) through the JNK-FOXO3 axis to modulate cancer drug resistance and clonal survival. Mol Cell Endocrinol. 2020;515:110932.
Lomelino CL, Andring JT, McKenna R, Kilberg MS. Asparagine synthetase: function, structure, and role in disease. J Biol Chem. 2017;292(49):19952–8.
Deng L, Yao P, Li L, Ji F, Zhao S, Xu C, et al. p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival. Nat Commun. 2020;11(1):1755.
Apfel V, Begue D, Cordo’ V, Holzer L, Martinuzzi L, Buhles A, et al. Therapeutic assessment of targeting ASNS combined with l-asparaginase treatment in solid tumors and investigation of resistance mechanisms. ACS Pharmacol Transl Sci. 2021;4(1):327–37.
You do not currently have access to this content.